- Investing Ideas
- Global Pharmaceuticals & Biotech High ROE Growth Engines
Global Pharmaceuticals & Biotech High ROE Growth Engines
Results
57
57 companies
Incyte
Market Cap: US$24.9b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$119.52
7D
1.6%
1Y
58.1%
Exelixis
Market Cap: US$14.1b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$53.03
7D
-4.2%
1Y
42.3%
Orion Oyj
Market Cap: €11.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€81.10
7D
3.4%
1Y
15.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥50.0b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥111.20
7D
-6.7%
1Y
12.9%
Abbott India
Market Cap: ₹590.4b
Operates as a pharmaceutical company in India.
500488
₹27,784.15
7D
-0.8%
1Y
-17.5%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥36.6b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥40.80
7D
-4.4%
1Y
11.5%
3SBio
Market Cap: HK$41.7b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$16.72
7D
-3.2%
1Y
-44.6%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥32.3b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥122.10
7D
-10.2%
1Y
7.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹449.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,653.45
7D
5.6%
1Y
-9.6%
ACADIA Pharmaceuticals
Market Cap: US$4.5b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$25.87
7D
4.1%
1Y
9.9%
Ajanta Pharma
Market Cap: ₹432.8b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,465.20
7D
2.8%
1Y
28.6%
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,000.00
7D
-2.0%
1Y
-15.8%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥25.6b
Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.
600329
CN¥38.29
7D
4.6%
1Y
-1.2%
Xiamen Amoytop Biotech
Market Cap: CN¥23.8b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥58.35
7D
-0.9%
1Y
-35.7%
Sumitomo Pharma
Market Cap: JP¥559.8b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,248.00
7D
-2.8%
1Y
1.0%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.55
7D
-0.4%
1Y
10.2%
Zealand Pharma
Market Cap: DKK 21.4b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 304.00
7D
4.0%
1Y
-7.2%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س9.6b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س137.00
7D
-1.4%
1Y
-15.3%
CareDx
Market Cap: US$2.3b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$43.71
7D
17.7%
1Y
257.7%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.2b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.48
7D
9.9%
1Y
-0.2%
HBM Holdings
Market Cap: HK$10.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.18
7D
-2.6%
1Y
35.0%
CORONA Remedies
Market Cap: ₹128.4b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,098.80
7D
-0.7%
1Y
n/a
BioGaia
Market Cap: SEK 11.7b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 115.60
7D
0%
1Y
21.1%
ChemoMetec
Market Cap: DKK 7.5b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 432.60
7D
6.2%
1Y
-11.0%
Theravance Biopharma
Market Cap: US$873.3m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$16.86
7D
0%
1Y
54.7%
Sanofi India
Market Cap: ₹76.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,320.20
7D
-2.0%
1Y
-40.2%
Oscotec
Market Cap: ₩1.1t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩30,050.00
7D
-3.2%
1Y
-1.8%
CorMedix
Market Cap: US$587.6m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.53
7D
-4.3%
1Y
-35.3%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.0b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س57.90
7D
-2.9%
1Y
-14.8%
Rafa Laboratories
Market Cap: ₪1.6b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪16.31
7D
4.7%
1Y
n/a
DHG Pharmaceutical
Market Cap: ₫12.1t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫92,600.00
7D
1.9%
1Y
-8.9%
Elite Pharmaceuticals
Market Cap: US$401.4m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.38
7D
-2.2%
1Y
-22.0%
GlaxoSmithKline Pakistan
Market Cap: PK₨110.1b
A biopharma company, engages in the discovery, development, and delivery of medicines and vaccines in Pakistan.
GLAXO
PK₨345.65
7D
0.9%
1Y
-17.1%
Abeona Therapeutics
Market Cap: US$368.8m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$6.42
7D
6.1%
1Y
-1.1%
Onconic Therapeutics
Market Cap: ₩491.3b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩10,820.00
7D
-1.1%
1Y
82.6%
Compugen
Market Cap: US$220.9m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.35
7D
3.1%
1Y
58.8%